Asian alliance hones Otsuka's focus and feeds Kyowa Kirin's regional ambitions
This article was originally published in Scrip
Executive Summary
Otsuka Pharmaceutical has entered into its second major alliance in less than eight months, this time with fellow Japanese firm Kyowa Hakko Kirin in a deal for diabetes and oncology that on closer examination aligns well with both companies' strategic aims.